Clinical Trials · NCT06124807
A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 179
- Start date
- Nov 2023
- Locations
- 29 sites, United States
- Primary endpoint
- Percent Change From Baseline in Body Weight at Week 32